Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia

被引：67

作者：

Deenik, W. ^{[1
]}

Beverloo, H. B. ^{[2
]}

van der Poel-van de Luytgaarde, S. C. P. A. M. ^{[1
]}

Wattel, M. M. ^{[2
]}

van Esser, J. W. J. ^{[3
]}

Valk, P. J. M. ^{[1
]}

Cornelissen, J. J. ^{[1
]}

机构：

[1] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands

[2] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands

[3] Amphia Hosp, Dept Internal Med, Breda, Netherlands

来源：

LEUKEMIA | 2009年 / 23卷 / 03期

关键词：

AMPLIFIED EPISOMES; FUSION; NUP214; ABL1;

D O I：

10.1038/leu.2008.318

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：627 / 629

页数：4

共 8 条

[1] Amplification of the ABL gene in T-cell acute lymphoblastic leukemia [J].

Barber, KE ;

Martineau, M ;

Harewood, L ;

Stewart, M ;

Cameron, E ;

Strefford, JC ;

Rutherford, S ;

Allen, TD ;

Broadfield, ZJ ;

Cheung, KL ;

Harris, RL ;

Jalali, GR ;

Moorman, AV ;

Robinson, HM ;

Harrison, CJ .

LEUKEMIA, 2004, 18 (06) :1153-1156

[2] NUP214-ABL1 in adult T-ALL:: the GMALL study group experience [J].

Burmeister, Thomas ;

Gokbuget, Nicola ;

Reinhardt, Richard ;

Rieder, Harald ;

Hoelzer, Dieter ;

Schwartz, Stefan .

BLOOD, 2006, 108 (10) :3556-3559

[3]

DEKEERSMAECKER K, 2008, LEUKEMIA

[4]

DEKEERSMAECKER K, 2008, HAEMATOLOGICA, V93

[5] In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) [J].

Goldstone, Anthony H. ;

Richards, Susan M. ;

Lazarus, Hillard M. ;

Tallman, Martin S. ;

Buck, Georgina ;

Fielding, Adele K. ;

Burnett, Alan K. ;

Chopra, Raj ;

Wiernik, Peter H. ;

Foroni, Letizia ;

Paietta, Elisabeth ;

Litzow, Mark R. ;

Marks, David I. ;

Durrant, Jill ;

McMillan, Andrew ;

Franklin, Ian M. ;

Luger, Selina ;

Ciobanu, Niculae ;

Rowe, Jacob M. .

BLOOD, 2008, 111 (04) :1827-1833

[6] Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia [J].

Graux, C ;

Cools, J ;

Melotte, C ;

Quentmeier, H ;

Ferrando, A ;

Levine, R ;

Vermeesch, JR ;

Stul, M ;

Dutta, B ;

Boeckx, N ;

Bosly, A ;

Heimann, P ;

Uyttebroeck, A ;

Mentens, N ;

Somers, R ;

MacLeod, RAF ;

Drexler, HG ;

Look, AT ;

Gilliland, DG ;

Michaux, L ;

Vandenberghe, P ;

Wlodarska, I ;

Marynen, P ;

Hagemeijer, A .

NATURE GENETICS, 2004, 36 (10) :1084-1089

[7] Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies [J].

Quintas-Cardama, A. ;

Tong, W. ;

Manshouri, T. ;

Vega, F. ;

Lennon, P. A. ;

Cools, J. ;

Gilliland, D. G. ;

Lee, F. ;

Cortes, J. ;

Kantarjian, H. ;

Garcia-Manero, G. .

LEUKEMIA, 2008, 22 (06) :1117-1124

[8] Fusion of NUP214 to ABL1 on amplified episomes in T-ALL - implications for treatment [J].

Stergianou, K ;

Fox, C ;

Russell, N .

LEUKEMIA, 2005, 19 (09) :1680-1681

← 1 →